Bio-Reference Laboratories, Inc. Announces Earnings Date for the First

    Business Editors/Health/Medical Writers

    ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Feb. 24, 2005--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the first quarter of fiscal 2005 before the open of market trading on Thursday, March 3, 2005. The Company's earnings conference call is to take place the same day at 10:30 a.m. Eastern Time. The call will be hosted by Marc D. Grodman M.D., President and Chief Executive Officer.
    The live Web cast will be available at the Company's corporate Web site, www.bioreference.com and through www.streetevents.com. To listen to the live call please go to the Web site ten minutes before the conference call is scheduled to begin. You will need to register as well as download and install any necessary audio software. The Web cast will be archived, on both Web sites, for 30 days following the call.

    About Bio-Reference Laboratories, Inc.

    The Company is the largest independent regional clinical laboratory in the Northeast and has major market positions in physician offices, nursing homes and correctional institutions. The Company is a full service clinical laboratory with specialty capability, especially in the areas of genomics, oncology, correctional health, and complementary medicine. PSIMedica, a business unit of the Company, is a clinical knowledge management (CKM) organization offering an array of information solutions for reducing healthcare costs and improving quality performance that are based on a flexible, scalable software analytical engine that utilizes all available source information, including claims data, enrollment data, prescription data and laboratory data. The Company provides a comprehensive connectivity solution to physicians that includes disease management, laboratory reporting and ordering, as well as claims and eligibility processing through CareEvolve, its web-based healthcare portal.

    www.bioreference.com

--30--SS/ny*

CONTACT: Bio-Reference Laboratories, Inc. Investor Relations Coordinator Kara Kelly, 201-791-2600 Fax: 201-791-1941 kkelly@bioreference.com

KEYWORD: NEW JERSEY INDUSTRY KEYWORD: PHARMACEUTICAL MEDICAL BIOTECHNOLOGY BANKING CONFERENCE CALLS EARNINGS SOURCE: Bio-Reference Laboratories, Inc.

Copyright Business Wire 2005